secwatch / observer
8-K filed April 28, 2023, 7:59 PM ET ticker SNTI CIK 0001854270
leadership confidence high sentiment neutral materiality 0.30

Director David R. Epstein resigns from Senti board effective June 16, 2023

Senti Biosciences, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

David R. Epstein

Director
SNTI · Senti Biosciences, Inc.
Effective
2023-06-16
Filed
April 28, 2023, 7:59 PM ET
Mr. David R. Epstein, informed the board of directors (the “Board”) of Senti Biosciences, Inc. (“Senti”) of his intention to resign as a director of Senti, including resignation from all the committees of the Board on which he serves, effective as of the close of business on June 16, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David R. Epstein resigned as Director at Senti Biosciences, Inc..

Action
resigned
Role
Director
Exact text from the filing
Mr. David R. Epstein, informed the board of directors (the “Board”) of Senti Biosciences, Inc. (“Senti”) of his intention to resign as a director of Senti, including resignation from all the committees of the Board on which he serves, effective as of the close of business on June 16, 2023.
View on SEC.gov

Senti Biosciences, Inc. filing history →

Source: SEC EDGAR
accession 0001854270-23-000044
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.